Correlation Between Oncologix Tech and Bellatora

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncologix Tech and Bellatora at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncologix Tech and Bellatora into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncologix Tech and Bellatora, you can compare the effects of market volatilities on Oncologix Tech and Bellatora and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncologix Tech with a short position of Bellatora. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncologix Tech and Bellatora.

Diversification Opportunities for Oncologix Tech and Bellatora

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Oncologix and Bellatora is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncologix Tech and Bellatora in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellatora and Oncologix Tech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncologix Tech are associated (or correlated) with Bellatora. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellatora has no effect on the direction of Oncologix Tech i.e., Oncologix Tech and Bellatora go up and down completely randomly.

Pair Corralation between Oncologix Tech and Bellatora

Given the investment horizon of 90 days Oncologix Tech is expected to under-perform the Bellatora. But the pink sheet apears to be less risky and, when comparing its historical volatility, Oncologix Tech is 1.06 times less risky than Bellatora. The pink sheet trades about -0.21 of its potential returns per unit of risk. The Bellatora is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  85.00  in Bellatora on September 1, 2024 and sell it today you would lose (24.00) from holding Bellatora or give up 28.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Oncologix Tech  vs.  Bellatora

 Performance 
       Timeline  
Oncologix Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncologix Tech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Bellatora 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bellatora are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Bellatora reported solid returns over the last few months and may actually be approaching a breakup point.

Oncologix Tech and Bellatora Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncologix Tech and Bellatora

The main advantage of trading using opposite Oncologix Tech and Bellatora positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncologix Tech position performs unexpectedly, Bellatora can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellatora will offset losses from the drop in Bellatora's long position.
The idea behind Oncologix Tech and Bellatora pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators